Luton, Bedfordshire, United Kingdom, May 26, 2025 (GLOBE NEWSWIRE) — Market Overview
Digital Therapeutics & Medical Devices Market Size and Growth
The global Digital Therapeutics & Medical Devices Market was valued at USD 7.88 billion in 2024 and is projected to reach USD 56.76 billion by 2034, growing at a CAGR of 21.65% during the forecast period.
Get a Sample PDF Brochure: https://exactitudeconsultancy.com/reports/44634/digital-therapeutics-medical-devices-for-migraine-market#request-a-sample
Digital Therapeutic Devices Market Insights
The digital therapeutic devices segment is also witnessing robust growth, with the market expected to expand from USD 4.86 billion in 2024 to USD 14.0 billion by 2035.
The Digital Therapeutics (DTx) market refers to the use of software-based interventions to prevent, manage, or treat medical disorders or diseases. These solutions are evidence-based, often prescribed by healthcare professionals, and delivered through apps, wearables, or connected platforms. DTx is distinct from general wellness apps due to its clinical validation and regulatory oversight.
The Medical Devices market includes all instruments, machines, implants, and software that are used for medical purposes, such as diagnosis, treatment, and patient monitoring. When merged with digital therapeutics, it creates a powerful ecosystem combining hardware, data analytics, AI, and user-centric care delivery.
Regional Analysis
North America
- Market Share: Held the largest share at 43.91% in 2024, attributed to advanced healthcare infrastructure and supportive regulatory policies.
Europe
- Market Dynamics: Countries like Germany, the UK, and France are leading due to robust healthcare systems and government initiatives promoting digital healthcare solutions.
Asia-Pacific
- Growth Potential: Expected to witness the fastest growth, driven by increasing healthcare digitization and a rising prevalence of chronic diseases.
Browse full Report – https://exactitudeconsultancy.com/reports/44634/digital-therapeutics-medical-devices-for-migraine-market
Key Therapeutic Areas
Diabetes Management
- Market Share: Dominated the digital therapeutics market with a 29.75% revenue share in 2024.
Mental Health
- Market Value: Valued at USD 1.5 billion in 2024, reflecting growing awareness and demand for digital interventions in mental health.
Cardiovascular Diseases
- Market Value: Estimated at USD 1.0 billion in 2024, with digital solutions aiding in managing heart-related ailments.
Key Market Players
Digital Therapeutics Companies (2025)
| No. | Company Name | Headquarters | Focus Areas |
| 1 | Omada Health | USA | Chronic disease management, AI-driven nutrition |
| 2 | Hinge Health | USA | Musculoskeletal care, AI-powered physical therapy |
| 3 | Sword Health | Portugal | Virtual physical therapy, AI integration |
| 4 | Click Therapeutics | USA | Prescription digital therapeutics for mental health |
| 5 | Kaia Health | Germany | AI-driven chronic pain management |
| 6 | DarioHealth | USA | Diabetes, hypertension, weight management |
| 7 | Virta Health | USA | Type 2 diabetes reversal |
| 8 | Pear Therapeutics | USA | Digital treatments for addiction and mental health |
| 9 | Big Health | USA | Mental health solutions, including insomnia and anxiety |
| 10 | Teladoc Health | USA | Telemedicine, chronic condition management |
| 11 | Lark Health | USA | AI-based chronic disease management |
| 12 | Maven Clinic | USA | Women’s and family health |
| 13 | Talkspace | USA | Online therapy and mental health services |
| 14 | CureApp, Inc. | Japan | Mobile applications for chronic disease management |
| 15 | GAIA AG | Germany | Evidence-based therapeutic apps |
| 16 | Welldoc, Inc. | USA | Diabetes management through digital platforms |
| 17 | 2Morrow Inc. | USA | Smoking cessation and weight management |
| 18 | Reperio Health | USA | At-home health assessments |
| 19 | Thirty Madison | USA | Specialized virtual care for chronic conditions |
| 20 | Meru Health | USA | Digital mental health programs |
Buy Now : https://exactitudeconsultancy.com/purchase/?currency=USD&type=single_user_license&report_id=44634
Medical Device Companies (2025)
| No. | Company Name | Headquarters | Specialization |
| 1 | Medtronic | Ireland | Cardiovascular, diabetes, surgical devices |
| 2 | Johnson & Johnson | USA | Surgical instruments, implants, diagnostics |
| 3 | Abbott Laboratories | USA | Diabetes care, diagnostics, vascular devices |
| 4 | Siemens Healthineers | Germany | Imaging systems, laboratory diagnostics |
| 5 | GE Healthcare | USA | Imaging systems, medical devices, IT solutions |
| 6 | Philips Healthcare | Netherlands | Imaging systems, patient monitoring |
| 7 | Stryker Corporation | USA | Orthopedics, neurotechnology, surgical equipment |
| 8 | Boston Scientific | USA | Interventional cardiology, neuromodulation |
| 9 | Becton Dickinson (BD) | USA | Medical diagnostics, IV sets, syringes |
| 10 | Danaher Corporation | USA | Diagnostics, life sciences, dental equipment |
Recent Developments
1. Hinge Health’s Successful IPO and AI Integration
In May 2025, Hinge Health, a digital physical therapy company, went public with a strong debut, reaching a $2.6 billion valuation. The company reported an 81% gross margin and $17.1 million profit in Q1 2025. Hinge Health utilizes AI-powered tools for motion tracking and care coordination, significantly reducing clinician hours and enhancing care delivery. The company plans to expand into additional healthcare specialties, further automating care with technology.
2. Medtronic’s Diabetes Division Spin-Off
Medtronic announced plans to spin off its diabetes division into a standalone company. The new entity will be led by Que Dallara, current head of the diabetes division, and will employ around 8,000 people. This move aims to allow Medtronic to concentrate on its more lucrative businesses, especially heart devices. The separation is expected to be completed within 18 months.
3. Siemens Healthineers Faces Tariff Challenges
Siemens Healthineers’ …